• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未控制的哮喘:患者管理中未满足的需求

Uncontrolled Asthma: Unmet Needs in the Management of Patients.

作者信息

Caminati Marco, Vaia Rachele, Furci Fabiana, Guarnieri Gabriella, Senna Gianenrico

机构信息

Department of Medicine, University of Verona, Verona, Italy.

Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.

出版信息

J Asthma Allergy. 2021 May 3;14:457-466. doi: 10.2147/JAA.S260604. eCollection 2021.

DOI:10.2147/JAA.S260604
PMID:33976555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8104981/
Abstract

The recent scientific research has provided clinicians with the tools for substantially upgrading the standard of care in the field of bronchial asthma. Nevertheless, satisfactory asthma control still remains an unmet need worldwide. Identifying the major determinants of poor control in different asthma severity levels represents the first step towards the improvement of the overall patients' management. The present review aims to provide an overview of the main unmet needs in asthma control and of the potential tools for overcoming the issue. Implementing a personalized medicine approach is essential, not only in terms of pharmacological treatments, biologic drugs or sophisticated biomarkers. In fact, exploring the complex profile of each patient, from his inflammation phenotype to his preferences and expectations, may help in filling the gap between the big potential of currently available treatments and the overall unsatisfactory asthma control. Telemedicine and e-health technologies may provide a strategy to both optimize disease assessment on a regular basis and enhance patients' empowerment in managing their asthma. Increasing patients' awareness as well as the physicians' knowledge about asthma phenotypes and treatment options besides corticosteroid probably represent the key and more difficult goals of all the players involved in asthma management at every level.

摘要

最近的科学研究为临床医生提供了大幅提升支气管哮喘领域护理标准的工具。然而,在全球范围内,令人满意的哮喘控制仍然是未被满足的需求。确定不同哮喘严重程度水平下控制不佳的主要决定因素是改善整体患者管理的第一步。本综述旨在概述哮喘控制方面主要未被满足的需求以及克服该问题的潜在工具。实施个性化医疗方法至关重要,不仅在药物治疗、生物药物或复杂生物标志物方面。事实上,探究每个患者的复杂特征,从其炎症表型到其偏好和期望,可能有助于填补当前可用治疗的巨大潜力与整体不尽人意的哮喘控制之间的差距。远程医疗和电子健康技术可能提供一种策略,既能定期优化疾病评估,又能增强患者管理哮喘的能力。除了皮质类固醇之外,提高患者对哮喘表型和治疗选择的认识以及医生的相关知识,可能是各级参与哮喘管理的所有人员的关键且更具挑战性的目标。

相似文献

1
Uncontrolled Asthma: Unmet Needs in the Management of Patients.未控制的哮喘:患者管理中未满足的需求
J Asthma Allergy. 2021 May 3;14:457-466. doi: 10.2147/JAA.S260604. eCollection 2021.
2
Towards precision medicine: The application of omics technologies in asthma management.迈向精准医学:组学技术在哮喘管理中的应用。
F1000Res. 2018 Apr 4;7:423. doi: 10.12688/f1000research.14309.2. eCollection 2018.
3
Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights.重度嗜酸性粒细胞性哮喘的抗白细胞介素-5疗法:文献综述与实践见解
J Asthma Allergy. 2020 Sep 9;13:301-313. doi: 10.2147/JAA.S258594. eCollection 2020.
4
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
5
Unmet needs in asthma.哮喘未满足的需求。
Ther Clin Risk Manag. 2019 Mar 14;15:409-421. doi: 10.2147/TCRM.S160327. eCollection 2019.
6
Needs for Systems Approaches to Better Treat Individuals With Severe Asthma: Predicting Phenotypes and Responses to Treatments.采用系统方法更好地治疗重度哮喘患者的需求:预测表型和治疗反应
Front Med (Lausanne). 2020 Mar 31;7:98. doi: 10.3389/fmed.2020.00098. eCollection 2020.
7
An algorithmic approach for the treatment of severe uncontrolled asthma.一种治疗严重难治性哮喘的算法方法。
ERJ Open Res. 2018 Mar 6;4(1). doi: 10.1183/23120541.00125-2017. eCollection 2018 Jan.
8
The management of severe asthma in 2020.2020 年严重哮喘的管理。
Biochem Pharmacol. 2020 Sep;179:114112. doi: 10.1016/j.bcp.2020.114112. Epub 2020 Jun 27.
9
Asthma phenotypes and endotypes: a personalized approach to treatment.哮喘的表型和内型:个性化治疗方法
Curr Opin Pulm Med. 2016 Jan;22(1):3-9. doi: 10.1097/MCP.0000000000000225.
10
Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective.儿童哮喘治疗的最新进展:临床药理学视角。
Expert Rev Clin Pharmacol. 2022 Oct;15(10):1165-1176. doi: 10.1080/17512433.2022.2131537. Epub 2022 Oct 6.

引用本文的文献

1
Why Every Asthma Patient Tells a Different Story.为何每位哮喘患者的情况各不相同。
J Clin Med. 2025 Aug 9;14(16):5641. doi: 10.3390/jcm14165641.
2
Identifying Treatable Traits of Patients with Asthma Prescribed an ICS/LABA: A Descriptive Analytic Database Study in England.识别使用吸入性糖皮质激素/长效β2受体激动剂治疗的哮喘患者的可治疗特征:一项在英国开展的描述性分析数据库研究
Adv Ther. 2025 Aug 19. doi: 10.1007/s12325-025-03332-2.
3
Guideline-based asthma treatment in Asia: Insights from a robust time-in-state model.亚洲基于指南的哮喘治疗:来自稳健状态时间模型的见解。

本文引用的文献

1
Uncontrolled asthma across GINA treatment steps 2 - 5 in a large US patient cohort.美国一大群患者队列中,全球哮喘防治创议(GINA)治疗步骤2至5的未控制哮喘情况。
J Asthma. 2022 May;59(5):1051-1062. doi: 10.1080/02770903.2021.1897834. Epub 2021 Mar 31.
2
Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review.呼出一氧化氮分数作为哮喘临床进程的决定因素:一项系统评价
Eur Clin Respir J. 2021 Feb 24;8(1):1891725. doi: 10.1080/20018525.2021.1891725.
3
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit.
J Allergy Clin Immunol Glob. 2025 Jul 1;4(4):100531. doi: 10.1016/j.jacig.2025.100531. eCollection 2025 Nov.
4
Perceptions and practices of community pharmacists towards the use of short-acting beta-2 agonists inhalers in Malaysia: A cross-sectional survey.马来西亚社区药剂师对使用短效β-2激动剂吸入器的认知与实践:一项横断面调查。
PLoS One. 2025 Jun 11;20(6):e0324982. doi: 10.1371/journal.pone.0324982. eCollection 2025.
5
Evaluation of a competency-based CPD programme for pharmacists on asthma care: a feasibility study.针对药剂师的哮喘护理能力本位持续专业发展计划评估:一项可行性研究。
Saudi Pharm J. 2025 Jun 4;33(3):14. doi: 10.1007/s44446-025-00021-7.
6
Air Pollution Increases Healthcare Utilization Below Safe Thresholds in Individuals With Asthma.空气污染增加了哮喘患者低于安全阈值的医疗保健利用率。
Allergy Asthma Immunol Res. 2025 May;17(3):349-358. doi: 10.4168/aair.2025.17.3.349.
7
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation.芳烃受体:一个经修复的治疗性免疫调节靶点。
Nat Rev Drug Discov. 2025 Apr 17. doi: 10.1038/s41573-025-01172-x.
8
Asthma control and opportunities to optimize management and the healthcare provider experience using the AsthmaOptimiser online tool in Dutch general practice: the CAPTURE study.在荷兰全科医疗中使用AsthmaOptimiser在线工具控制哮喘及优化管理与医疗服务提供者体验的机会:CAPTURE研究
NPJ Prim Care Respir Med. 2025 Apr 15;35(1):23. doi: 10.1038/s41533-025-00427-9.
9
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment.嗜酸性粒细胞驱动型与嗜酸性粒细胞相关型重度哮喘:靶向治疗的实际意义
Int J Mol Sci. 2025 Feb 18;26(4):1729. doi: 10.3390/ijms26041729.
10
The potential role of nanobodies in asthma therapy.纳米抗体在哮喘治疗中的潜在作用。
Front Pharmacol. 2025 Jan 20;15:1510806. doi: 10.3389/fphar.2024.1510806. eCollection 2024.
如何评估哮喘生物制剂的疗效,以及在没有获益时应采取的措施。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1081-1088. doi: 10.1016/j.jaip.2020.10.048.
4
A Systematic Review and Meta-Analysis of Change in Health-Related Quality of Life for Interactive Telehealth Interventions for Patients With Asthma.一项针对互动远程医疗干预对哮喘患者健康相关生活质量变化的系统评价和荟萃分析。
Value Health. 2021 Feb;24(2):291-302. doi: 10.1016/j.jval.2020.09.006. Epub 2020 Oct 24.
5
Biologics and global burden of asthma: A worldwide portrait and a call for action.生物制剂与哮喘的全球负担:一幅全球图景及行动呼吁。
World Allergy Organ J. 2021 Jan 6;14(2):100502. doi: 10.1016/j.waojou.2020.100502. eCollection 2021 Feb.
6
The Impact of Tobacco Smoking on Adult Asthma Outcomes.吸烟对成人哮喘结局的影响。
Int J Environ Res Public Health. 2021 Jan 23;18(3):992. doi: 10.3390/ijerph18030992.
7
The effect of video presentation showed in the outpatient clinic waiting area on the success of inhaler device use in chronic respiratory diseases.在门诊候诊区播放视频对慢性呼吸道疾病患者吸入装置使用成功率的影响。
Heart Lung. 2021 Mar-Apr;50(2):323-328. doi: 10.1016/j.hrtlng.2021.01.009. Epub 2021 Jan 20.
8
The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study.当地药房评估哮喘控制情况的潜在作用:一项意大利横断面研究。
BMC Public Health. 2021 Jan 5;21(1):19. doi: 10.1186/s12889-020-10080-1.
9
Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data set.哮喘患者的不依从性和不持续性程度:一项大型理赔数据集分析。
J Asthma. 2022 Apr;59(4):829-839. doi: 10.1080/02770903.2021.1871738. Epub 2021 Jan 20.
10
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.在生物制剂时代的英国严重哮喘注册研究中对严重哮喘患者的特征描述。
Thorax. 2021 Mar;76(3):220-227. doi: 10.1136/thoraxjnl-2020-215168. Epub 2020 Dec 9.